Advancements and challenges in brain cancer therapeutics
Exploration · 2024-12 · 4 (6)
DOI: 10.1002/exp.20230177 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 16.05.2024. Verfasst von Fan Bai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Paul C Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering Shenzhen Institute of Advanced Technology Chi…. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Treating brain tumors requires a nuanced understanding of the brain, a vital and delicate organ. Location, size, tumor type, and surrounding tissue health are crucial in developing treatment plans. This review comprehensively summarizes various treatment options that are available or could be potentially available for brain tumors, including physical therapies (radiotherapy, ablation therapy, photodynamic therapy, tumor‐treating field therapy, and cold atmospheric plasma therapy) and non‐physical therapies (surgical resection, chemotherapy, targeted therapy, and immunotherapy). Mechanisms of action, potential side effects, indications, and latest developments, as well as their limitations, are highlighted. Furthermore, the requirements for personalized, multi‐modal treatment approaches in this rapidly evolving field are discussed, emphasizing the balance between efficacy and patient safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paul C Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen China.
- Advanced Therapeutic Center National Innovation Center for Advanced Medical Devices Shenzhen China.
- Department of Biomedical Engineering McGill University Montreal Quebec Canada.
- Rosalind & Morris Goodman Cancer Institute McGill University Montreal Quebec Canada.
- University of Chinese Academy of Sciences Shenzhen Guangdong P. R. China.
- Department of Medical Engineering Medical Supplies Center of Chinese PLA General Hospital Beijing China.
ORCID-Profile: Guojun Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Bai, F., Deng, Y., Li, L., Lv, M., Razzokov, J., Xu, Q., Xu, Z., Chen, Z., Chen, G., & Chen, Z. (2024). Advancements and challenges in brain cancer therapeutics. Exploration, 4(6). https://doi.org/10.1002/exp.20230177
Vancouver
Bai F, Deng Y, Li L, Lv M, Razzokov J, Xu Q, et al. Advancements and challenges in brain cancer therapeutics. Exploration. 2024;4(6). doi:10.1002/exp.20230177
BibTeX
@article{Bai2024,
author = {Bai, Fan and Deng, Yueyang and Li, Long and Lv, Ming and Razzokov, Jamoliddin and Xu, Qingnan and Xu, Zhen and Chen, Zhaowei and Chen, Guojun and Chen, Zhitong},
title = {Advancements and challenges in brain cancer therapeutics},
journal = {Exploration},
year = {2024},
volume = {4},
number = {6},
doi = {10.1002/exp.20230177}
}
EUVIMED